1988
DOI: 10.1016/0014-2999(88)90163-x
|View full text |Cite
|
Sign up to set email alerts
|

6,7-Dinitro-quinoxaline-2,3-dion and 6-nitro,7-cyano-quinoxaline-2,3-dion antagonise responses to NMDA in the rat spinal cord via an action at the strychnine-insensitive glycine receptor

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
71
0
4

Year Published

1989
1989
2017
2017

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 193 publications
(80 citation statements)
references
References 6 publications
5
71
0
4
Order By: Relevance
“…The possibility can be ruled out, however, that a cross-effect between the two antagonists occurred. Although CNQX may act on NMDA receptors via the glycine site, this requires much higher concentrations (3 X lo-' M; Birch et al, 1988) than what we used to block the synaptic drive. With the antagonist concentrations used here, however, it can be assumed on the basis of two arguments that an almost complete blockade of the receptors was obtained: (1) the complete disappearance of the EPSPs elicited by the sensory afferent stimulation in the presence of AP-5 and CNQX (see Material and Methods, data not shown); and (2) the effect of AP-5 and CNQX on the locomotor-like rhythm (Cazalets et al, 1992;Sqalli-Houssaini et al, 1993b), which was abolished completely at these concentrations.…”
Section: Lumbar Spinal Cordmentioning
confidence: 99%
“…The possibility can be ruled out, however, that a cross-effect between the two antagonists occurred. Although CNQX may act on NMDA receptors via the glycine site, this requires much higher concentrations (3 X lo-' M; Birch et al, 1988) than what we used to block the synaptic drive. With the antagonist concentrations used here, however, it can be assumed on the basis of two arguments that an almost complete blockade of the receptors was obtained: (1) the complete disappearance of the EPSPs elicited by the sensory afferent stimulation in the presence of AP-5 and CNQX (see Material and Methods, data not shown); and (2) the effect of AP-5 and CNQX on the locomotor-like rhythm (Cazalets et al, 1992;Sqalli-Houssaini et al, 1993b), which was abolished completely at these concentrations.…”
Section: Lumbar Spinal Cordmentioning
confidence: 99%
“…Although species differences cannot be completely excluded, examination of this study shows that it was done using CNQX as a specific blocker of AMPA receptors. CNQX has been widely described as being also an antagonist at NMDA-Rs, in part by competing with glycine at its modulatory site (Birch et al, 1988;Harris and Miller, 1989;Kessler et al, 1989;Pellegrini-Giampietro et al, 1989;Lester and Jahr, 1990;Mead and Stephens, 1999) and also with glutamate at its binding site (Lester and Jahr, 1990). In contrast, NBQX has no effect on NMDA currents (Sheardown et al, 1990).…”
Section: Cnqx Partly Blocks the Nmda-mediated Cf-epscmentioning
confidence: 99%
“…6-cyano-7-nitroquinoxaline-2.3-dione (CNQX, 10/tM) to block non-NMDA receptors (Blake, Brown & Collingridge, 1988;Honore, Davies, Drejer, Fletcher, Jacobsen, Lodge & Nielsen, 1988) and glycine (10 /tM) to ensure saturation of the glycine binding sites of NMDA receptors (Thomson, Walker & Flynn, 1989) and to increase the selectivity of CNQX to the non-NMDA receptors (Birch, Grossmann & Hayes, 1988 (Kostyuk. Krishtal & Pidoplichko, 1975;Kay, Miles & Wong, 1986), thus improving space clamp.…”
Section: Solutions and Drugsmentioning
confidence: 99%